Pharmacokinetics of paclitaxel and three major metabolites in patients with advanced breast carcinoma refractory to anthracycline therapy treated with a 3-hour paclitaxel infusion: A European Cancer Centre (ECC) trial

M.T. Huizing, J.B. Vermorken, H. Rosing, ok [Unknown], I. Mandjes, H.M. Pinedo, J.H. Beijnen

Research output: Contribution to journalArticleAcademicpeer-review

56 Downloads (Pure)
Original languageEnglish
Pages (from-to)699-704
JournalAnnals of Oncology
Publication statusPublished - 1995

Cite this